DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

111.40 -1.49 (-1.32%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRTX $111.40 -1.32%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $114.43
Previous Close $112.89
Daily Range $110.62 - $114.43
52-Week Range $59.79 - $118.17
Market Cap $26.8B
P/E Ratio -57.02
Dividend (Yield) $0.00 (0.0%)
Volume 1,299,241
Average Daily Volume 1,553,479
Current FY EPS -$2.82

Sector

Healthcare

Industry

Drugs

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

News & Commentary

Is This Trend Making Gilead Sciences, Inc. Worry?

In a bid to control costs, healthcare payers are restricting who can be prescribed Gilead Sciences' Harvoni.

Nasdaq 100 Movers: VRTX, ADSK

Nasdaq 100 Movers: GMCR, DLTR

Insider Trading Alert - LNKD, VRTX And RLGY Traded By Insiders

Royalty Pharma's $3.3 Billion Transaction is Bullish for Vertex Pharma

Barbarian At The Gate: Vertex Pharmaceuticals (VRTX)

Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analys

Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analyst Blog

Stock Market News for November 11, 2014 - Market News

Weekly CFO Sells Highlight: Texas Instruments Inc, Royal Caribbean Cruises Ltd, Vertex ...

Vertex Pharmaceuticals Seeks Approval for CF Combination - Analyst Blog

3 Stocks Moving The Drugs Industry Upward

See More VRTX News...

VRTX's Top Competitors

VRTX $111.40 (-1.32%)
Current stock: VRTX
AMGN $162.81 (0.08%)
Current stock: AMGN
GILD $100.58 (-0.01%)
Current stock: GILD
BIIB $303.55 (1.49%)
Current stock: BIIB